178
Participants
Start Date
February 16, 2004
Primary Completion Date
April 15, 2009
Study Completion Date
April 15, 2009
TWINRIX™ ADULT
2 doses IM injection in primary study
Engerix TM
If a subject has become seronegative for anti-HAV antibodies or lost anti-HBs seroprotection concentrations at the long-term blood sampling time point (i.e. Years 6, 7, 8, 9 or 10), he/ she will be offered an additional vaccine dose.
GSK Investigational Site, Wilrijk
Lead Sponsor
GlaxoSmithKline
INDUSTRY